Effect of lysophosphatidylglycerol on several signaling molecules in OVCAR-3 human ovarian cancer cells: Involvement of pertussis toxin-sensitive G-protein coupled receptor

Biochemical Pharmacology

Volumn 73, Issue 5, 2007, Pages 675-681

  Park, Kyoung Sun ^a   Kim, Mi Kyoung ^a   Im, Dong Soon ^b   Bae, Yoe Sik ^a  

^a Dong A University   (South Korea)

^b Pusan National University   (South Korea)

Author keywords

G protein coupled receptor; Intracellular calcium increase; Lysophosphatidylglycerol; Ovarian cancer cell; Pertussis toxin sensitive G protein

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 2,5 PYRROLIDINEDIONE; CALCIUM ION; G PROTEIN COUPLED RECEPTOR; GLYCEROL DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PERTUSSIS TOXIN; PHOSPHOLIPASE C; PROTEIN KINASE B;

ARTICLE; CALCIUM CELL LEVEL; CANCER CELL CULTURE; CELL STRAIN HEPG2; CELL TYPE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION;

CALCIUM SIGNALING; CELL LINE, TUMOR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; LYSOPHOSPHOLIPIDS; ONCOGENE PROTEIN V-AKT; OVARIAN NEOPLASMS; PERTUSSIS TOXIN; RECEPTORS, LYSOPHOSPHATIDIC ACID;

EID: 33846493012     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2006.11.010     Document Type: Article

References (33)

1. Graler M.H., and Goetzl E.J. Lysophospholipids and their G protein-coupled receptors in inflammation and immunity. Biochim Biophys Acta 1582 (2002) 168-174
2. Steiner M.R., Urso J.R., Klein J., and Steiner S.M. Multiple astrocyte responses to lysophosphatidic acids. Biochim Biophys Acta 1582 (2002) 154-160
3. Fang X., Schummer M., Mao M., Yu S., Tabassam F.H., Swaby R., et al. Lysophosphatidic acid is a bioactive mediator in ovarian cancer. Biochim Biophys Acta 1582 (2002) 257-264
4. Xie Y., Gibbs T.C., Mukhin Y.V., and Meier K.E. Role for 18:1 lysophosphatidic acid as an autocrine mediator in prostate cancer cells. J Biol Chem 277 (2002) 32516-32526
5. Kim J.I., Jo E.J., Lee H.Y., Kang H.K., Lee Y.N., Kwak J.Y., et al. Stimulation of early gene induction and cell proliferation by lysophosphatidic acid in human amnion-derived WISH cells: role of phospholipase D-mediated pathway. Biochem Pharmacol 68 (2004) 333-340
6. Hama K., Aoki J., Fukaya M., Kishi Y., Sakai T., Suzuki R., et al. Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1. J Biol Chem 279 (2004) 17634-17639
7. Ren J., Xiao Y.J., Singh L.S., Zhao X., Zhao Z., Feng L., et al. Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells. Cancer Res 66 (2006) 3006-3014
8. Budnik L.T., and Mukhopadhyay A.K. Lysophosphatidic acid antagonizes the morphoregulatory effects of the luteinizing hormone on luteal cells: possible role of small Rho-G-proteins. Biol Reprod 65 (2001) 180-187
9. Daaka Y. Mitogenic action of LPA in prostate. Biochim Biophys Acta 1582 (2002) 265-269
10. Dowhan W. Molecular basis for membrane phospholipid diversity: why are there so many lipids?. Annu Rev Biochem 66 (1997) 199-232
11. Yang Y., Cao J., and Shi Y. Identification and characterization of a gene encoding human LPGAT1, an endoplasmic reticulum-associated lysophosphatidylglycerol acyltransferase. J Biol Chem 279 (2004) 55866-55874
12. van der Bend R.L., Brunner J., Jalink K., van Corven E.J., Moolenaar W.H., and van Blitterswijk W.J. Identification of a putative membrane receptor for the bioactive phospholipid, lysophosphatidic acid. EMBO J 11 (1992) 2495-2501
13. Xu Y., Fang X.J., Casey G., and Mills G.B. Lysophospholipids activate ovarian and breast cancer cells. Biochem J 309 (1995) 933-940
14. Kim M.K., Lee H.Y., Park K.S., Shin E.H., Jo S.H., Yun J., et al. Lysophosphatidic acid stimulates cell proliferation in rat chondrocytes. Biochem Pharmacol 70 (2005) 1764-1771
15. Kim J.I., Jo E.J., Lee H.Y., Cha M.S., Min J.K., Choi C.H., et al. Sphingosine 1-phosphate in amniotic fluid modulates cyclooxygenase-2 expression in human amnion-derived WISH cells. J Biol Chem 278 (2003) 31731-31736
16. Li Q., Roberts A.C., and Glanzman D.L. Synaptic facilitation and behavioral dishabituation in Aplysia: dependence on release of Ca2+ from postsynaptic intracellular stores, postsynaptic exocytosis, and modulation of postsynaptic AMPA receptor efficacy. J Neurosci 25 (2005) 5623-5637
17. Rao R.V., and Ellerby H.M. Bredesen DE coupling endoplasmic reticulum stress to the cell death program. Cell Death Differ 11 (2004) 372-380
18. Jo E.J., Lee H.Y., Lee Y.N., Kim J.I., Kang H.K., Park D.W., et al. Group IB secretory phospholipase A2 stimulates CXC chemokine ligand 8 production via ERK and NF-kappa B in human neutrophils. J Immunol 173 (2004) 6433-6439
19. Chernyavsky A.I., Arredondo J., Karlsson E., Wessler I., and Grando S.A. The Ras/Raf-1/MEK1/ERK signaling pathway coupled to integrin expression mediates cholinergic regulation of keratinocyte directional migration. J Biol Chem 280 (2005) 39220-39228
20. Kim D., and Chung J. Akt: versatile mediator of cell survival and beyond. J Biochem Mol Biol 35 (2002) 106-115
21. Bae Y.S., Bae H., Kim Y., Lee T.G., Suh P.G., and Ryu S.H. Identification of novel chemoattractant peptides for human leukocytes. Blood 97 (2001) 2854-2862
22. Bae Y.S., Yi H.J., Lee H.Y., Jo E.J., Kim J.I., Lee T.G., et al. Differential activation of formyl peptide receptor-like 1 by peptide ligands. J Immunol 171 (2003) 6807-6813
23. Kim M.K., Lee H.Y., Kwak J.Y., Park J.I., Yun J., and Bae Y.S. Sphingosine-1-phosphate stimulates rat primary chondrocyte proliferation. Biochem Biophys Res Commun 345 (2006) 67-73
24. Johnson G.L., and Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298 (2002) 1911-1912
25. Morales-Ruiz M., Lee M.J., Zollner S., Gratton J.P., Scotland R., Shiojima I., et al. Sphingosine 1-phosphate activates Akt, nitric oxide production, and chemotaxis through a Gi protein/phosphoinositide 3-kinase pathway in endothelial cells. J Biol Chem 276 (2001) 19672-19677
26. Murrin R.J., and Boarder M.R. Neuronal "nucleotide" receptor linked to phospholipase C and phospholipase D? Stimulation of PC12 cells by ATP analogues and UTP. Mol Pharmacol 41 (1992) 561-568
27. Frankel A., and Mills G.B. Peptide and lipid growth factors decrease cis-diamminedichloroplatinum-induced cell death in human ovarian cancer cells. Clin Cancer Res 2 (1996) 1307-1313
28. Lin P., Welch E.J., Gao X.P., Malik A.B., and Ye R.D. Lysophosphatidylcholine modulates neutrophil oxidant production through elevation of cyclic AMP. J Immunol 174 (2005) 2981-2989
29. Yan J.J., Jung J.S., Lee J.E., Lee J., Huh S.O., Kim H.S., et al. Therapeutic effects of lysophosphatidylcholine in experimental sepsis. Nat Med 10 (2004) 161-167
30. Park K.S., Lee H.Y., Kim M.K., Shin E.H., and Bae Y.S. Lysophosphatidylserine stimulates leukemic cells but not normal leukocytes. Biochem Biophys Res Commun 333 (2005) 353-358
31. Park K.S., Lee H.Y., Kim M.K., Shin E.H., Jo S.H., Kim S.D., et al. Lysophosphatidylserine stimulates L2071 mouse fibroblast chemotactic migration via a process involving pertussis toxin-sensitive trimeric G-proteins. Mol Pharmacol 69 (2006) 1066-1073
32. Sugo T., Tachimoto H., Chikatsu T., Murakami Y., Kikukawa Y., Sato S., et al. Identification of a lysophosphatidylserine receptor on mast cells. Biochem Biophys Res Commun 341 (2006) 1078-1087
33. Noguchi K., Ishii S., and Shimizu T. Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family. J Biol Chem 278 (2003) 25600-25606